111 Inc (YI) Forward P/E Multiple

Symbol and logo of brand 111, Inc (YI)

111, Inc. integrates telemedicine with retail, radically simplifying access to treatment. The company's forward P/E shift confirms this technological breakthrough, with the metric currently standing at 0.00. Meanwhile, the business relies on a B2B ecosystem amid strict government price regulations. The company has now transitioned from extensive expansion toward logistics optimization and the pursuit of real profitability.

111, Inc (YI) Forward P/E Multiple: for the period 07/04/2022 - 11/12/2026

Analytical breakdowns for 111, Inc.

- stock quotes and analyst forecast:
Stock Price 111, Inc.|YI - Analyst Consensus Forecast
- market capitalization details:
Market Capitalization 111, Inc|YI - Real Price to Acquire Entire Company
- book capitalization information:
Accounting Value of a Share 111, Inc.|YI - Book Capitalization|Market Capitalization to Book Value 111.com.cn|YI - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Ratio 111, Inc.|YI - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio 111, Inc.|YI - Company Total Debt|Debts to Net Assets 111, Inc.|YI - Company Long-Term Liabilities|Short-Term Debt 111, Inc.|Interim Coverage Ratio 111.com.cn
- earnings and market multiples details:
YI - Company Net Income|Forward Earnings 111, Inc.|YI - P/E Multiple|Future Price to Earnings Multiple 111, Inc.|YI - PEG Multiple|EV/EBITDA Multiple 111, Inc|YI - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year 111, Inc.|YI - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months 111.com.cn|YI - Earnings growth in current year|Earnings growth forecast for next year 111, Inc.
Fundamental company analysis:111 Inc., YI
Original product of 111.com.cn

Forward P/E is calculated as the ratio of the current market share price to the expected earnings per share in the next period, measuring market expectations regarding future business efficiency. Amid low margins and regulatory risks in China, the projected P/E of 111, Inc. allows for an assessment of the company's resilience to operating losses, helping investors find a balance between risk and return.

Competitors of 111, Inc.

Forward P/E Multiple CVS|Forward P/E Multiple McKesson Corp (MCK)|Forward P/E Multiple COR (AmerisourceBergen)|CAH - Projected Price to Earnings|Future Price to Earnings Multiple Henry Schein, Inc. (HSIC)|PBH - Forward P/E Multiple|wellgisticshealth.com - Market Cap to Projected Earnings|RDGT (China Jo-Jo Drugstores, Inc.) - Future Price to Earnings|Price to Future Earnings Ratio Universe Pharmacy (UPC)|Forward P/E Multiple Biodexa Pharma|Projected Price to Earnings HKPD (Hong Kong Pharma Digital)|Projected Price to Earnings usbimi.com BIMI|Market Cap to Projected Earnings CJJD|WBA - Projected Price to Earnings